SCHEMBL3977140

SCHEMBL3977140

COc1ccc(COC(c2ccc(OC(COc3ccc(C=O)cc3)c3ccccc3)cc2)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.40
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
SLC6A4 P31645 5/20 0.36
SLC6A2 P23975 4/20 0.36
SLC6A3 Q01959 4/20 0.36
LMNA P02545 4/20 0.36
HRH3 Q9Y5N1 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
MTOR P42345 2/20 0.36
KCNK2 O95069 2/20 0.36
KCNH2 Q12809 2/20 0.36
CACNA1C Q13936 2/20 0.36
CYP3A4 P08684 2/20 0.36
HTR2C P28335 2/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980162 0.89 HTR1A (0.42) HTR1ARAB9ANPC1MEN1KMT2A
SCHEMBL3985462 0.85 NR1H2 (0.44) HTR1ARAB9ANPC1MEN1KMT2A
SCHEMBL3979827 0.78 NR1H2 (0.44) RAB9ANPC1MEN1KMT2ASLC6A4
SCHEMBL3980660 0.77 NR1H2 (0.42) HTR1ALMNASLC6A9
SCHEMBL3984317 0.76 NR1H3 (0.47) MEN1KMT2AALDH1A1FFAR1SLC6A9
SCHEMBL3981070 0.75 NR1H3 (0.41) MEN1KMT2AFFAR1SLC6A9
SCHEMBL5613806 0.73 PPARG (0.43) TDP1MEN1KMT2ASLC6A4KDM4E
SCHEMBL3982043 0.72 SLC6A9 (0.41) HTR1ATDP1SLC6A4HRH3CHRM3
SCHEMBL3981219 0.70 PPARG (0.43) RAB9ANPC1TDP1KDM4EALOX15
SCHEMBL3985565 0.70 PPARG (0.43) RAB9ANPC1TDP1KDM4EALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7473705-B2 Hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. (US) 2009-01-06 US disclosed
EP-1802566-B1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-11-26 EP disclosed
EP-1802566-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-04 EP disclosed
WO-2006037480-A1 HEXAFLUOROISOPROPANOL SUBSTITUTED ETHER DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2006-04-13 WO disclosed
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives HOFFMANN-LA ROCHE INC. 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074115-A1 Novel hexafluoroisopropanol substituted ether derivatives NR1H3, NR1H2, NR1I2 HTR1A 1893/4885RAB9A 3090/4885NPC1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.